Cristina Larkin
Net Worth
Last updated:
What is Cristina Larkin net worth?
The estimated net worth of Ms. Cristina Larkin is at least $5,117,640 as of 16 Dec 2020. She owns shares worth $2,760 as insider and has received compensation worth at least $5,114,880 in Spero Therapeutics, Inc..
What is the salary of Cristina Larkin?
Ms. Cristina Larkin salary is $639,360 per year as Chief Operating Officer in Spero Therapeutics, Inc..
How old is Cristina Larkin?
Ms. Cristina Larkin is 55 years old, born in 1970.
What stocks does Cristina Larkin currently own?
As insider, Ms. Cristina Larkin owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | Chief Operating Officer | 1,500 | $1.84 | $2,760 |
What does Spero Therapeutics, Inc. do?
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, a direct acting IV-administered agent to treat MDR Gram-negative bacterial infections in the hospital; and SPR720, an oral antibiotic for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; license agreement with Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; collaboration agreement with Bill & Melinda Gates Medical Research Institute to develop SPR720 for the treatment of lung infections caused by Mycobacterium tuberculosis; and license agreement with Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Cristina Larkin insider trading
Spero Therapeutics, Inc.
Ms. Cristina Larkin has made 2 insider trades between 2017-2020, according to the Form 4 filled with the SEC.
The largest trade she's ever made was exercising 12,000 units of SPRO stock on 16 Dec 2020. As of 16 Dec 2020 she still owns at least 1,500 units of SPRO stock.
Spero Therapeutics key executives
Spero Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Ankit Mahadevia M.D., MBA (44) Co-Founder, Chief Executive Officer, Pres & Director
- Dr. David A. Melnick M.D. (73) Chief Medical Officer
- Ms. Cristina Larkin (55) Chief Operating Officer